Lamotrigine Patent Expiration
Lamotrigine was first introduced by Glaxosmithkline Llc
Lamotrigine Patents
Given below is the list of patents protecting Lamotrigine, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Lamictal Xr | US8637512 | Formulations and method of treatment | Jan 07, 2029 | Glaxosmithkline Llc |
| Lamictal Odt | US7919115 | Orally disintegrating tablet compositions of lamotrigine | Jan 04, 2029 | Glaxosmithkline Llc |
| Lamictal Odt | US8840925 | Orally disintegrating tablet compositions of lamotrigine | Jul 02, 2028 | Glaxosmithkline Llc |
| Lamictal Odt | US9339504 | Orally disintegrating tablet compositions of lamotrigine | Jul 02, 2028 | Glaxosmithkline Llc |
| Lamictal Xr | US9144547 | Oral dosage form for controlled drug release |
Sep 22, 2023
(Expired) | Glaxosmithkline Llc |
| Lamictal Cd |
US5698226 (Pediatric) | Water-dispersible tablets |
Jul 29, 2012
(Expired) | Glaxosmithkline Llc |
Lamotrigine's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List